Oct 27, 2022 / 09:30AM GMT
Presentation
Oct 27, 2022 / 09:30AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Director of IR
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Giles Platford
Takeda Pharmaceutical Company Limited - President of the Plasma-Derived Therapies Business Unit
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Masato Iwasaki
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
* Teresa Bitetti
Takeda Pharmaceutical Company Limited - President of the Global Oncology Business Unit
=====================
Takeda Pharmaceutical Co Ltd
(FRA:TKD)
€
25.47
-0.14 (-0.55%)
Market Cap: 40.55 Bil
Enterprise Value: 65.84 Bil
PE Ratio: 23.04
PB Ratio: 0.96
GF Score: 82/100 Q2 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Oct 27, 2022 / 09:30AM GMT
Release Date Price:
€25.91
(+0.62%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot